Literature DB >> 26195222

Tetanus toxoid-loaded layer-by-layer nanoassemblies for efficient systemic, mucosal, and cellular immunostimulatory response following oral administration.

Harshad Harde1, Ashish Kumar Agrawal, Sanyog Jain.   

Abstract

The present study reports the tetanus toxoid (TT)-loaded layer-by-layer nanoassemblies (layersomes) with enhanced protection, permeation, and presentation for comprehensive oral immunization. The stable and lyophilized TT-loaded layersomes were prepared by a thin-film hydration method followed by alternate layer-by-layer coating of an electrolyte. The developed system was assessed for in vitro stability of antigen and formulation, cellular uptake, ex vivo intestinal uptake, and immunostimulatory response using a suitable experimental protocol. Layersomes improved the stability in simulated biological media as well as protected the integrity/conformation and native 3D structure of TT as confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), circular dichroism (CD), and fluorescence spectroscopy, respectively. The cell culture studies demonstrated a 3.8-fold higher permeation of layersomes in Caco-2 cells and an 8.5-fold higher uptake by antigen-presenting cells (RAW 264.7). The TT-loaded layersomes elicited a complete immunostimulatory profile consisting of higher systemic (serum IgG titer), mucosal (sIgA titer), and cellular (interleukin-2 (IL-2) and interferon-γ (IFN-γ) levels) immune response after peroral administration in mice. The modified TT inhibition assay further confirmed the elicitation of complete protective levels of anti-TT antibody (>0.1 IU/mL) by layersomes. In conclusion, the proposed strategy is expected to contribute significantly in the field of stable liposome technology for mass immunization through the oral route.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26195222     DOI: 10.1007/s13346-015-0247-x

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  32 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization.

Authors:  Amit K Jain; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

3.  Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity.

Authors:  Jamie F S Mann; Hannah E Scales; Eisin Shakir; James Alexander; Katharine C Carter; Alexander B Mullen; Valerie A Ferro
Journal:  Methods       Date:  2006-02       Impact factor: 3.608

4.  Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.

Authors:  Sanyog Jain; Dinesh Kumar; Nitin K Swarnakar; Kaushik Thanki
Journal:  Biomaterials       Date:  2012-06-29       Impact factor: 12.479

5.  Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.

Authors:  M Singh; X M Li; H Wang; J P McGee; T Zamb; W Koff; C Y Wang; D T O'Hagan
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.

Authors:  M Isaka; Y Yasuda; S Kozuka; Y Miura; T Taniguchi; K Matano; N Goto; K Tochikubo
Journal:  Vaccine       Date:  1998-10       Impact factor: 3.641

7.  Tetanus toxoids loaded glucomannosylated chitosan based nanohoming vaccine adjuvant with improved oral stability and immunostimulatory response.

Authors:  Harshad Harde; Ashish Kumar Agrawal; Sanyog Jain
Journal:  Pharm Res       Date:  2014-07-17       Impact factor: 4.200

8.  Downstream Processing, Formulation Development and Antithrombotic Evaluation of Microbial Nattokinase.

Authors:  Rohit Kapoor; Harshad Harde; Sanyog Jain; Amulya Kumar Panda; Bibhu Prasad Panda
Journal:  J Biomed Nanotechnol       Date:  2015-07       Impact factor: 4.099

9.  Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.

Authors:  Amit K Jain; Kaushik Thanki; Sanyog Jain
Journal:  Mol Pharm       Date:  2013-08-08       Impact factor: 4.939

10.  Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles.

Authors:  Xinran Li; Abdulaziz M Aldayel; Zhengrong Cui
Journal:  J Control Release       Date:  2013-11-01       Impact factor: 9.776

View more
  4 in total

1.  Development of self-nanoemulsifying drug delivery system for oral bioavailability enhancement of valsartan in beagle dogs.

Authors:  Zhenbao Li; Wenjuan Zhang; Yan Gao; Rongwu Xiang; Yan Liu; Mingming Hu; Mei Zhou; Xiaohong Liu; Yongjun Wang; Zhonggui He; Yinghua Sun; Jin Sun
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

2.  Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.

Authors:  Deepa Dehari; Abhishesh Kumar Mehata; Vishnu Priya; Dharmnath Parbat; Deepak Kumar; Anand Kumar Srivastava; Sanjay Singh; Ashish Kumar Agrawal
Journal:  AAPS PharmSciTech       Date:  2022-06-24       Impact factor: 4.026

Review 3.  Mucosal Vaccine Development Based on Liposome Technology.

Authors:  Valentina Bernasconi; Karin Norling; Marta Bally; Fredrik Höök; Nils Y Lycke
Journal:  J Immunol Res       Date:  2016-12-29       Impact factor: 4.818

Review 4.  Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.

Authors:  Blaise Corthésy; Gilles Bioley
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.